← Leaderboards
James Walter Kazura
Case Western Reserve University
$29,330,012
Attributed
$31,705,115
Total exposure
17
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,103,626 · 20
By mechanism
U19$28,945,130 · 8
R01$14,778,808 · 6
U54$2,653,007 · 2
T32$2,639,832 · 1
D43$1,591,247 · 2
U01$1,495,602 · 1
Top collaborators
- Douglas T. Golenbock4 shared
- Katherine Rose Dobbs3 shared
- Peter A. Zimmerman3 shared
- Peter Max Siba1 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Peter A. Zimmerman$15,255,586
- Ivo J Mueller$5,820,723
- Christopher L King$14,576,924
- Edwin Michael$976,265
- Katherine Rose Dobbs$1,381,030
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
MalariaPlasmodium FalciparumTransmission ProcessInfectionAreaMorbidity - Disease RateImmuneParasitesSiteBloodAfricaVectorBaseImmunityEpidemiologyProteinsPrevalenceAfrica South Of The SaharaMediatingChildAffectKenyaPeripheral Blood Mononuclear CellComplex
Grant awards (98)
Innate Immune Mechanisms Governing Subclinical Malaria in Children$764,343
R01 · FY2025 · AI · contact PI
Impact of early-life pathogen exposures on pre-erythrocytic malaria vaccine effectiveness in Kenyan infants$347,184
R01 · FY2025 · AI
Impact of early-life pathogen exposures on pre-erythrocytic malaria vaccine effectiveness in Kenyan infants$286,080
R01 · FY2025 · AI
Impact of early-life pathogen exposures on pre-erythrocytic malaria vaccine effectiveness in Kenyan infants$48,936
R01 · FY2025 · AI
Innate Immune Mechanisms Governing Subclinical Malaria in Children$763,783
R01 · FY2024 · AI · contact PI
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria$1,078,945
U19 · FY2023 · AI · contact PI
Innate Immune Mechanisms Governing Subclinical Malaria in Children$764,349
R01 · FY2023 · AI · contact PI
Innate Immune Mechanisms Governing Subclinical Malaria in Children$737,656
R01 · FY2022 · AI · contact PI
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria$407,861
U19 · FY2022 · AI · contact PI
Kruppel-Like Factor 2 Counters Vascular and Immunologic Dysfunction in Child Cerebral Malaria$576,496
R01 · FY2021 · AI · contact PI
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria$384,021
U19 · FY2021 · AI · contact PI
Kruppel-Like Factor 2 Counters Vascular and Immunologic Dysfunction in Child Cerebral Malaria$576,496
R01 · FY2020 · AI · contact PI
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria$476,152
U19 · FY2020 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$256,787
T32 · FY2020 · AI · contact PI
Kruppel-Like Factor 2 Counters Vascular and Immunologic Dysfunction in Child Cerebral Malaria$592,696
R01 · FY2019 · AI · contact PI
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria$291,055
U19 · FY2019 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$260,037
T32 · FY2019 · AI · contact PI
Kruppel-Like Factor 2 Counters Vascular and Immunologic Dysfunction in Child Cerebral Malaria$611,314
R01 · FY2018 · AI · contact PI
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria$383,300
U19 · FY2018 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$263,622
T32 · FY2018 · AI · contact PI
Kruppel-Like Factor 2 Counters Vascular and Immunologic Dysfunction in Child Cerebral Malaria$616,909
R01 · FY2017 · AI · contact PI
Impact of Environmental Modifications on Pathogenesis and Immunity of Plasmodium falciparum and P. vivax Malaria$400,113
U19 · FY2017 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$202,745
T32 · FY2017 · AI · contact PI
Research to control and eliminate malaria in SE Asia and SW Pacific$1,474,468
U19 · FY2016 · AI · contact PI
Administration$733,024
U19 · FY2016 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$257,183
T32 · FY2016 · AI · contact PI
Research to control and eliminate malaria in SE Asia and SW Pacific$1,550,071
U19 · FY2015 · AI · contact PI
Administration$737,440
U19 · FY2015 · AI · contact PI
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken$618,210
R01 · FY2015 · AI · contact PI
Case-PNG Global Infectious Disease Research Training Program (D43)$260,031
D43 · FY2015 · TW · contact PI
Research to control and eliminate malaria in SE Asia and SW Pacific$1,569,425
U19 · FY2014 · AI · contact PI
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken$634,125
R01 · FY2014 · AI · contact PI
Administration$271,786
U19 · FY2014 · AI · contact PI
Case-PNG Global Infectious Disease Research Training Program (D43)$258,328
D43 · FY2014 · TW · contact PI
Training in Geographic Medicine and Infectious Diseases$163,652
T32 · FY2014 · AI · contact PI
Research to control and eliminate malaria in SE Asia and SW Pacific$1,512,673
U19 · FY2013 · AI · contact PI
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken$613,990
R01 · FY2013 · AI · contact PI
Innate immune factor in host susceptibility to rift valley fever virus$385,851
U54 · FY2013 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$266,601
T32 · FY2013 · AI · contact PI
Case-PNG Global Infectious Disease Research Training Program (D43)$253,065
D43 · FY2013 · TW · contact PI
Administration$242,494
U19 · FY2013 · AI · contact PI
Research to control and eliminate malaria in SE Asia and SW Pacific$1,175,567
U19 · FY2012 · AI · contact PI
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken$650,352
R01 · FY2012 · AI · contact PI
Administration$403,521
U19 · FY2012 · AI · contact PI
Innate immune factor in host susceptibility to rift valley fever virus$358,424
U54 · FY2012 · AI · contact PI
Case-PNG Global Infectious Disease Research Training Program (D43)$266,452
D43 · FY2012 · TW · contact PI
Research to Control and Eliminate Malaria in SE Asia and SW Pacific AI089686 Comp$250,000
U19 · FY2012 · AI · contact PI
Research to Control and Eliminate Malaria in SE Asia and SW Pacific U19AI089686$235,750
U19 · FY2012 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$231,331
T32 · FY2012 · AI · contact PI
Research to control and eliminate malaria in SE Asia and SW Pacific$1,149,888
U19 · FY2011 · AI · contact PI
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken$638,461
R01 · FY2011 · AI · contact PI
Innate immune factor in host susceptibility to rift valley fever virus$481,794
U54 · FY2011 · AI · contact PI
Administration$301,905
U19 · FY2011 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$271,573
T32 · FY2011 · AI · contact PI
Research to control and eliminate malaria in SE Asia and SW Pacific$962,158
U19 · FY2010 · AI · contact PI
Innate immune factor in host susceptibility to rift valley fever virus$497,452
U54 · FY2010 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$267,240
T32 · FY2010 · AI · contact PI
Administration$250,713
U19 · FY2010 · AI · contact PI
Mass drug treatment and vector control of filariasis$821,783
U19 · FY2009 · AI · contact PI
Innate immune factor in host susceptibility to rift valley fever virus$493,367
U54 · FY2009 · AI · contact PI
Impact of Mass Drug Administration with or Without Insecticide Impregnated Nets$489,072
U19 · FY2009 · AI · contact PI
Mass drug treatment and vector control of filariasis$814,086
U19 · FY2008 · AI · contact PI
Human immunity to MSP-1 in Western Kenya$589,100
R01 · FY2008 · AI · contact PI
Impact of Mass Drug Administration with or Without Insecticide Impregnated Nets$475,051
U19 · FY2008 · AI · contact PI
Human Immunity to Vaccinia Virus$436,119
U54 · FY2008 · AI · contact PI
Mass drug treatment and vector control of filariasis$859,864
U19 · FY2007 · AI · contact PI
Human immunity to MSP-1 in Western Kenya$585,339
R01 · FY2007 · AI · contact PI
Impact of Mass Drug Administration with or Without Insecticide Impregnated Nets$444,900
U19 · FY2007 · AI · contact PI
Training in Geographic Medicine and Infectious Diseases$199,061
T32 · FY2007 · AI · contact PI
Mass drug treatment and vector control of filariasis$888,219
U19 · FY2006 · AI · contact PI
Human immunity to MSP-1 in Western Kenya$621,826
R01 · FY2006 · AI · contact PI
Immunological memory to malaria liver stage antigens$339,871
R01 · FY2006 · AI · contact PI
Mass Drug Administration with or Without Insecticide$269,321
U19 · FY2006 · AI · contact PI
Mass drug treatment and vector control of filariasis$769,477
U19 · FY2005 · AI
Human immunity to MSP-1 in Western Kenya$586,712
R01 · FY2005 · AI
Immunological memory to malaria liver stage antigens$348,050
R01 · FY2005 · AI
Mass Drug Administration with or Without Insecticide$175,422
U19 · FY2005 · AI
Administrative Core$127,021
U19 · FY2005 · AI
HETEROGENEITY OF DISEASE IN LYMPHATIC FILARIASIS$856,661
U19 · FY2004 · AI
Human immunity to MSP-1 in Western Kenya$596,752
R01 · FY2004 · AI
Immunological memory to malaria liver stage antigens$348,050
R01 · FY2004 · AI
HETEROGENEITY OF DISEASE IN LYMPHATIC FILARIASIS$1,290,711
U19 · FY2003 · AI
Immunological memory to malaria liver stage antigens$348,050
R01 · FY2003 · AI
HETEROGENEITY OF DISEASE IN LYMPHATIC FILARIASIS$1,283,440
U19 · FY2002 · AI
IMMUNOLOGIC MEMORY TO PREERYTHROCYTIC P FALCIPARUM$511,573
U01 · FY2002 · AI
Immunological memory to malaria liver stage antigens$263,775
R01 · FY2002 · AI
RESEARCH TRAINING FOR ERID IN KENYA AND PAPUA NEW GUINEA$100,000
D43 · FY2002 · TW
TRANSMISSION IN IMMUNITY AND LYMPHATIC PATHOLOGY IN FILARIASIS$0
U19 · FY2002 · AI
HETEROGENEITY OF DISEASE IN LYMPHATIC FILARIASIS$1,275,421
U19 · FY2001 · AI
IMMUNOLOGIC MEMORY TO PREERYTHROCYTIC P FALCIPARUM$498,406
U01 · FY2001 · AI
RESEARCH TRAINING FOR ERID IN KENYA AND PAPUA NEW GUINEA$194,870
D43 · FY2001 · TW
TRANSMISSION IN IMMUNITY AND LYMPHATIC PATHOLOGY IN FILARIASIS$0
U19 · FY2001 · AI
HETEROGENEITY OF DISEASE IN LYMPHATIC FILARIASIS$1,658,849
U19 · FY2000 · AI
IMMUNOLOGIC MEMORY TO PREERYTHROCYTIC P FALCIPARUM$485,623
U01 · FY2000 · AI
T CELL IMMUNITY TO PREERYTHROCYTIC P FALCIPARUM$309,903
R01 · FY2000 · AI
RESEARCH TRAINING FOR ERID IN KENYA AND PAPUA NEW GUINEA$216,201
D43 · FY2000 · TW
TRANSMISSION IN IMMUNITY AND LYMPHATIC PATHOLOGY IN FILARIASIS$203,502
U19 · FY2000 · AI
RESEARCH TRAINING FOR ERID IN KENYA AND PAPUA NEW GUINEA$42,300
D43 · FY2000 · TW